Particle size, shape, surface charge, and stability can all affect texture, mouthfeel, appearance, shelf life, and processing performance. This article explores how particle characterization helps ...

Formulation development serves as a vital bridge between a drug substance and a drug product that will remain stable and ...

Total revenue of $140 million in the first quarter of 2026 Pfizer agreement announced in January for non-exclusive license to utilize Matrix-M® in two infectious ...

Improved Pharma is pleased to share two new publications in collaboration with Varda Space Industries. One recently published ...

Generic Semaglutide Injection developed by Orbicular receives Notice of Compliance from Health Canada — our second G-7 Approval by ...

Also Announces Extension of IR Program VANCOUVER, BC / ACCESS Newswire / May 1, 2026 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfurt: W1H, WKN: A3EKSZ) ("Onco" or the "Company") is ...

Following the success of the first volume of this Research Topic, which resulted in 17 published articles, this second edition continues to explore safe and ...

High-throughput virology, design of experiments, and small-molecule production enhancers optimize yield and increase ...

In this Pharma Matters Q&A, Anshul Gupte of PCI Pharma Services discusses investments and opportunities in sterile ...

Affinia Therapeutics (“Affinia”), an innovative gene therapy company with a pipeline of first-in-class and/or best-in-class adeno-associated virus (AAV) gene therapies initially for devastating ...